Tirzepatide has been approved for use on the NHS in Scotland
Tirzepatide (Mounjaro®) is accepted for restricted use within NHS Scotland by the SMC.
News
NICE has issued draft recommendations for the use of Mounjaro as a treatment for overweight or obesity
As of June 2024, the National Institute for Health and Care Excellence (NICE) has issued draft recommendations the use of Mounjaro as a treatment for overweight or obesity.
Tags
Guidance for the phased introduction of new medical therapies for weight management
A joint position statement by the Society for Endocrinology and Obesity Management Collaborative UK
This position statement is aimed at healthcare professionals working within weight management services, organisations delivering medical therapies for patients living with obesity, and commissioners of such services. Its objectives are to:
Tags
Semaglutide and the future of obesity care in the UK
Published in The Lancet, in June 2023, read this publication on the future of obesity care in the UK.